Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1998 1
2002 1
2003 1
2004 1
2005 3
2006 1
2007 1
2009 4
2010 2
2011 4
2012 1
2013 2
2014 3
2015 4
2016 5
2017 11
2018 10
2019 12
2020 8
2021 9
2022 12
2023 14
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

99 results

Results by year

Filters applied: . Clear all
Page 1
Overview and recent advances in the treatment of neuroblastoma.
Whittle SB, Smith V, Doherty E, Zhao S, McCarty S, Zage PE. Whittle SB, et al. Expert Rev Anticancer Ther. 2017 Apr;17(4):369-386. doi: 10.1080/14737140.2017.1285230. Epub 2017 Mar 15. Expert Rev Anticancer Ther. 2017. PMID: 28142287 Free article. Review.
Children with neuroblastoma have widely divergent outcomes, ranging from cure in >90% of patients with low risk disease to <50% for those with high risk disease. ...A combination of therapeutic modalities will likely be required to improve …
Children with neuroblastoma have widely divergent outcomes, ranging from cure in >90% of patients with low risk disease to …
Eflornithine for treatment of high-risk neuroblastoma.
Jiang J, Yu Y. Jiang J, et al. Trends Pharmacol Sci. 2024 Jun;45(6):577-578. doi: 10.1016/j.tips.2024.04.005. Epub 2024 May 14. Trends Pharmacol Sci. 2024. PMID: 38749882
[Image: see text] MECHANISM OF ACTION: Eflornithine (or DFMO) is a selective, small-molecule, irreversible inhibitor of ornithine decarboxylase (ODC, encoded by the gene ODC1), which is the enzyme responsible for the first and rate-limiting step in the biosynthesis of polyamines. …
[Image: see text] MECHANISM OF ACTION: Eflornithine (or DFMO) is a selective, small-molecule, irreversible inhibitor of ornithine decarboxyl …
Rethinking high-risk neuroblastoma treatment.
Cohn SL, Pearson ADJ. Cohn SL, et al. Pediatr Blood Cancer. 2022 Aug;69(8):e29730. doi: 10.1002/pbc.29730. Epub 2022 Apr 20. Pediatr Blood Cancer. 2022. PMID: 35441788 No abstract available.
Biological Insight and Recent Advancement in the Treatment of Neuroblastoma.
Rivera Z, Escutia C, Madonna MB, Gupta KH. Rivera Z, et al. Int J Mol Sci. 2023 May 9;24(10):8470. doi: 10.3390/ijms24108470. Int J Mol Sci. 2023. PMID: 37239815 Free PMC article. Review.
Unique characteristics of neuroblastoma includes its early age of onset, its propensity for spontaneous tumor regression in newborns, and its high prevalence of metastatic disease at diagnosis in individuals older than 1 year of age. Immunotherapeutic techniques hav …
Unique characteristics of neuroblastoma includes its early age of onset, its propensity for spontaneous tumor regression in newborns, …
Current Status and Future Perspective on Molecular Imaging and Treatment of Neuroblastoma.
Feng L, Li S, Wang C, Yang J. Feng L, et al. Semin Nucl Med. 2023 Jul;53(4):517-529. doi: 10.1053/j.semnuclmed.2022.12.004. Epub 2023 Jan 21. Semin Nucl Med. 2023. PMID: 36682980 Review.
In recent years, various tracers have been used for imaging neuroblastoma with PET. The importance of patient-specific targeted radionuclide therapy for neuroblastoma therapy has also increased. (131)I-MIBG therapy is part of the front-line trea …
In recent years, various tracers have been used for imaging neuroblastoma with PET. The importance of patient-specific targeted radio …
Pain mitigation and management strategies for anti-GD2 infusions: An expert consensus.
Nysom K, Morad AG, Rafael MS, Zier J, Marachelian A, Watt T, Morgenstern DA. Nysom K, et al. Pediatr Blood Cancer. 2023 May;70(5):e30217. doi: 10.1002/pbc.30217. Epub 2023 Feb 11. Pediatr Blood Cancer. 2023. PMID: 36772891
Monoclonal antibodies (mAbs) targeting disialoganglioside 2 (GD2) are an important treatment advance for high-risk neuroblastoma, including in patients with refractory or relapsed disease. ...
Monoclonal antibodies (mAbs) targeting disialoganglioside 2 (GD2) are an important treatment advance for high-risk neurobla …
Surgical Treatment of Neuroblastoma.
Ben Barak A, Golan H, Waldman D, Arkovitz MS. Ben Barak A, et al. Isr Med Assoc J. 2017 Nov;19(11):691-695. Isr Med Assoc J. 2017. PMID: 29185283 Free article.
The surgical treatment of high-risk neuroblastoma presents a challenge, and the benefits of aggressive surgical resection have been called into question. ...Overall, 3 year survival was 84% (21/25). CONCLUSIONS: Resection of neuroblastoma, even large, …
The surgical treatment of high-risk neuroblastoma presents a challenge, and the benefits of aggressive surgical resecti …
Treatment and outcome of adult-onset neuroblastoma.
Suzuki M, Kushner BH, Kramer K, Basu EM, Roberts SS, Hammond WJ, LaQuaglia MP, Wolden SL, Cheung NV, Modak S. Suzuki M, et al. Int J Cancer. 2018 Sep 1;143(5):1249-1258. doi: 10.1002/ijc.31399. Epub 2018 Apr 6. Int J Cancer. 2018. PMID: 29574715 Free PMC article.
Adult-onset neuroblastoma is rare and little is known about its biology and clinical course. There is no established therapy for adult-onset neuroblastoma. Anti-GD2 immunotherapy is now standard therapy in children with high-risk neuro …
Adult-onset neuroblastoma is rare and little is known about its biology and clinical course. There is no established therapy f …
Pharmacologic management of high-risk neuroblastoma in children.
Ganeshan VR, Schor NF. Ganeshan VR, et al. Paediatr Drugs. 2011 Aug 1;13(4):245-55. doi: 10.2165/11591630-000000000-00000. Paediatr Drugs. 2011. PMID: 21692548 Free PMC article. Review.
All peer reviewed, published human subject studies of therapy for neuroblastoma in children were included. Animal model and in vitro studies were included only if they added to the understanding of the mechanism of a proposed or existing human neuroblastoma …
All peer reviewed, published human subject studies of therapy for neuroblastoma in children were included. Animal model and in …
Advances in the Surgical Treatment of Neuroblastoma.
Luo YB, Cui XC, Yang L, Zhang D, Wang JX. Luo YB, et al. Chin Med J (Engl). 2018 Oct 5;131(19):2332-2337. doi: 10.4103/0366-6999.241803. Chin Med J (Engl). 2018. PMID: 30246719 Free PMC article. Review.
The search was conducted using the keywords "neuroblastoma," "neuroblastoma resection," "neuroblastoma surgery," and "high-risk neuroblastoma." ...We conclude that 90% resection of the primary tumor is both feasible and safe in most patie …
The search was conducted using the keywords "neuroblastoma," "neuroblastoma resection," "neuroblastoma surgery," and " …
99 results